39° Mostly Cloudy

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

60.31 -0.87 (-1.41%)

Streaming Delayed Price Updated: 10:53 AM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

44 45 Next >

A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US ↗

April 27, 2023

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...

Via Benzinga

Will Merck's Earnings Beat Give The Pharma Stock A Sorely Needed Boost? ↗

April 27, 2023

The company reported lighter-than-expected declines due to Keytruda and Gardasil.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 26, 2023

Via Benzinga

3 Biotechs That Might Get Bought Out in 2023 ↗

April 26, 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

Via The Motley Fool

Pharma Behemoths GSK, Roche Outplay Covid Declines To Beat Quarterly Calls ↗

April 26, 2023

Both GSK and Roche experienced declining Covid-related sales in the first quarter.

Via Investor's Business Daily

GSK Clocks 10% Growth In Q1 Sales Excluding COVID-19 Products, Reaffirms Guidance ↗

April 26, 2023

Via Benzinga

This Favorable Sign Appears On GSK's Chart ↗

April 14, 2023

Via Benzinga

This House of Representative Just Sold Up To $100K In GSK Stock ↗

April 05, 2023

Via Benzinga

Was This Acquisition a Savvy Play by This Big Pharma Stock? ↗

April 26, 2023

The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.

Via The Motley Fool

Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value ↗

April 25, 2023

Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)

April 25, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday ↗

April 25, 2023

The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.

Via The Motley Fool

Second Quarter Outlook For Biotech Stocks ↗

April 25, 2023

Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity.

Via Talk Markets

Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz ↗

April 24, 2023

Via Benzinga

United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review ↗

April 21, 2023

The Pan American Health Organization (PAHO) is reportedly in early talks with Takeda Pharmaceutical Co Ltd (NYSE: TAK) regarding the potential orders of its dengue vaccine, TAK-003.

Via Benzinga

Why Shares of Bellus Health Skyrocketed This Week ↗

April 20, 2023

The company has received a buyout offer from GSK.

Via The Motley Fool

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

April 18, 2023

From BELLUS Health Inc.

Via Business Wire

Why BELLUS Health Stock Is Rocketing Higher Today ↗

April 18, 2023

A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)

April 18, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal ↗

April 18, 2023

Shares of its takeover candidate nearly doubled on the news.

Via Investor's Business Daily

Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories ↗

April 18, 2023

Benzinga Elon Musk Drops Bombshell: US Intel Agencies Were Reading Your Twitter DMs

Via Benzinga

Why Is Bellus Health (BLU) Stock Up 98% Today? ↗

April 18, 2023

Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).

Via InvestorPlace

GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition ↗

April 18, 2023

Via Benzinga

Can Pfizer Beat GSK and Moderna in This $10 Billion Market? ↗

April 13, 2023

There's such a big need in preventing RSV that multiple companies should be big winners.

Via The Motley Fool

Why Shares of Adaptimmune Therapeutics Jumped Tuesday ↗

April 11, 2023

The company bulks up its pipeline by regaining the rights to two of its clinical programs.

Via The Motley Fool

Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments ↗

April 11, 2023

The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...

Via Benzinga

Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune

April 11, 2023

- Adaptimmune plans to be IND-ready in 2023 with a PRAME targeted TCR T-cell therapy -- Adaptimmune and GSK will...

Via Newsfile

Back from the Dead, IBM’s Watson AI is Alive and Re-Emerging

April 10, 2023

While artificial intelligence (AI) seems to have come around full circle in 2023 as ChatGPT finally lit the fuse for full-blown mainstream adoption, Internat

Via MarketBeat

Topics Artificial Intelligence

2 Top Biotech Stocks to Buy in April ↗

April 04, 2023

Right now you can pick up these stocks on the dip.

Via The Motley Fool

Could This Move by Johnson & Johnson Equal Billions for Moderna? ↗

April 02, 2023

An RSV vaccine could be a driver of blockbuster revenue.

Via The Motley Fool

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Sections

Services